An evidence-based patient guide to where PRP is well studied, where results are mixed, and why studies can appear to disagree.
Key message: The evidence for PRP is condition-specific. Knee osteoarthritis has the most mature evidence base; other musculoskeletal uses range from supportive to mixed or emerging. [3-7]
Why the answer is not simply yes or no
PRP research is difficult to interpret because studies often use different products under the same name. Blood draw volume, platelet dose, white-cell composition, injection technique, number of treatments and rehabilitation can vary substantially. Older studies also frequently failed to report enough biological detail to reproduce the treatment. [1-4]
This means a study of a low-dose, small-volume preparation placed without image guidance is not automatically testing the same intervention as a higher-dose, characterised product accurately delivered to a defined target.
Where is the evidence strongest?
Knee osteoarthritis is the most extensively studied musculoskeletal indication. European consensus guidance in 2024 concluded there was sufficient clinical evidence to support PRP for knee osteoarthritis, particularly mild to moderate disease. In 2026, AAPM&R published dedicated knee osteoarthritis guidance addressing patient selection, platelet dose, image guidance and rehabilitation. [6,7]
Recent systematic reviews also suggest that total platelet dose may influence knee osteoarthritis outcomes. A 2024 review identified a dose-response signal, and a 2025 review found that trials with positive outcomes had, on average, higher platelet doses than trials without significant benefit. [3,4]
Where is the evidence less certain?
Evidence for tendinopathy, ligament injury, muscle injury, nerve conditions and spinal applications is more heterogeneous. Some studies report meaningful improvement, while others show little difference from exercise, placebo or other care. Achilles tendinopathy is a good example: trials have produced mixed results, so rehabilitation remains central rather than PRP being treated as a replacement for loading-based care.
Emerging uses should be described as emerging. Case reports, small series and biological plausibility can be important signals for research, but they are not equivalent to large randomised trials.
What does “evidence-based PRP” mean in practice?
- Confirm the diagnosis before deciding that PRP is appropriate.
- Use a preparation whose dose and composition can be understood or measured.
- Choose an injection technique appropriate to the target anatomy.
- Use image guidance where it improves accuracy or safety.
- Build rehabilitation and load progression into the treatment plan.
- Measure outcomes and reconsider the diagnosis if the expected response does not occur.
Related Patient Guides
- PG8001 – PRP Injections: What Is Platelet-Rich Plasma and How Does It Work?
- PG8003 – Why Medicare Does Not Rebate PRP Injections in Australia
- PG8004 – How to Prepare for PRP: Supporting Your Healing Potential Before Treatment
- PG8005 – PRP Aftercare: Supporting Healing After Your Injection
- PG8006 – PRP Platelet Dose and Blood Draw Volume: Why the Numbers Matter
- PG8007 – How to Choose a PRP Provider: Questions to Ask Before You Book
- PG8008 – Why Image-Guided PRP Matters: Ultrasound and CT Guidance
- PG8009 – PRP Injection Accuracy and Documentation: Recording Final Needle Position
- PG8010 – How Many PRP Injections Will I Need? One Treatment vs a Series
Frequently Asked Questions
For other FAQs please visit our FAQs page
Is PRP “proven”?
For some indications, particularly knee osteoarthritis, the evidence is substantial enough for contemporary specialist guidance to support its use in selected patients. For other indications the evidence may be mixed or preliminary. “PRP” should never be treated as one universal therapy.
Can PRP regrow all cartilage or repair every tear?
No. Clinical improvement does not prove that a structure has completely regenerated. Claims about cartilage regrowth, ligament reconnection or structural healing require appropriate imaging or other objective evidence and should not be assumed for every patient.
Why did one PRP study show no benefit when another did?
Differences in diagnosis, disease severity, platelet dose, preparation, cellular composition, injection technique, number of treatments and rehabilitation can all contribute. Study quality also varies.
Does more PRP always mean better results?
No. Dose appears important in knee osteoarthritis, but there is no universal rule that the highest possible dose is best for every tissue. The target and formulation still matter.
| Important: This guide provides general information only. PRP suitability, medication changes, dosing, procedure choice and rehabilitation require individual clinical assessment. Evidence evolves; this guide reflects the literature reviewed for this document through August 2026. |
PATIENT GUIDE • PG-8002 [Patient information: An evidence-based patient guide to where PRP is well studied, where results are mixed, and why studies can appear to disagree.]
Searching for PRP treatment for knee pain on the Gold Coast?
PRP may be considered for selected patients with knee osteoarthritis, cartilage, meniscal or other musculoskeletal conditions after appropriate imaging and assessment.
